Brooks Laboratories Ltd

Brooks Laboratories Management Change

Brooks Laboratories Ltd announced the resignation of Ms. Krutika Rane, Company Secretary and Compliance Officer, effective October 9, 2026.

Brooks Laboratories Annual General Meeting

Brooks Laboratories Limited conducted its 24th Annual General Meeting on September 3, 2026. Shareholders transacted ordinary business, including the adoption of financial statements and director appointments.

Brooks Laboratories Annual General Meeting

Brooks Laboratories issued an addendum to its 24th Annual General Meeting notice. The amendment modifies Resolution No. 4 regarding corporate guarantee arrangements.

Brooks Laboratories Q1 FY27 Results: Net Loss of ₹1.8 Cr

Brooks Laboratories Ltd reported revenue from operations of ₹23 Cr (-9.8% YoY) and a net loss of ₹1.8 Cr for Q1 FY27.

Key figure

Net loss ₹1.8 Cr

Brooks Laboratories Other Announcement

Brooks Laboratories is informing shareholders about the availability of the Annual Report for FY 2025-26 and requesting KYC updates in compliance with regulatory requirements.

Brooks Laboratories Annual General Meeting

Brooks Laboratories Ltd has issued the notice for its 24th Annual General Meeting scheduled for September 3, 2026, along with the Annual Report for 2025-26.

Brooks Laboratories Board Meeting Date

Brooks Laboratories Limited announced a Board of Directors meeting on 13th August 2026 to approve the unaudited standalone and consolidated financial results.

Brooks Laboratories Management Change

Brooks Laboratories appointed Rajesh Mahajan as President - Trading effective July 17, 2026. He brings over 20 years of experience in pharmaceutical formulations and manufacturing operations.

Brooks Laboratories Merger & Restructuring Worth ₹106.3 Cr

Brooks Laboratories signed a binding MoU to sell a portion of its Brooks Steriscience stake. The deal provides Rs.106.33 Crore cash inflow and retains 32.67% equity.

Value

₹106.3 Cr

Execution

2 years

Brooks Laboratories Other Announcement

Brooks Laboratories Limited filed its shareholding pattern as per Regulation 31(1)(b). The filing details holdings across promoters, institutions, and public shareholders.